|
1
|
Ljungberg B, Campbell SC, Choi HY, Jacqmin
D, Lee JE, Weikert S and Kiemeney LA: The epidemiology of renal
cell carcinoma. Eur Urol. 60:615–621. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Castro A Jr, Jenkins LC, Salas N, Lorber G
and Leveillee RJ: Ablative therapies for small renal tumours. Nat
Rev Urol. 10:284–291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jonasch E, Gao J and Rathmell WK: Renal
cell carcinoma. BMJ. 349:g47972014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lardas M, Stewart F, Scrimgeour D, Hofmann
F, Marconi L, Dabestani S, Bex A, Volpe A, Canfield SE, Staehler M,
et al: Systematic review of surgical management of nonmetastatic
renal cell carcinoma with vena caval thrombus. Eur Urol.
70:265–280. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sanpakit K, Triwatanawong J and
Sumboonnanonda A: Long-term outcome in pediatric renal tumor
survivors: Experience of a single center. J Pediatr Hematol Oncol.
35:610–613. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xu Y, Wang J, Qiu M and Xu L, Li M, Jiang
F, Yin R and Xu L: Upregulation of the long noncoding RNA TUG1
promotes proliferation and migration of esophageal squamous cell
carcinoma. Tumour Biol. 36:1643–1651. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou X, Wang X, Huang Z, Wang J, Zhu W,
Shu Y and Liu P: Prognostic value of miR-21 in various cancers: An
updating meta-analysis. PLoS One. 9:e1024132014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev Genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lund E, Güttinger S, Calado A, Dahlberg JE
and Kutay U: Nuclear export of microRNA precursors. Science.
303:95–98. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Young TL, Matsuda T and Cepko CL: The
noncoding RNA taurine upregulated gene 1 is required for
differentiation of the murine retina. Curr Biol. 15:501–512. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Q, Geng PL, Yin P, Wang XL, Jia JP
and Yao J: Down-regulation of long non-coding RNA TUG1 inhibits
osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J
Cancer Prev. 14:2311–2315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang EB, Yin DD, Sun M, Kong R, Liu XH,
You LH, Han L, Xia R, Wang KM, Yang JS, et al: P53-regulated long
non-coding RNA TUG1 affects cell proliferation in human non-small
cell lung cancer, partly through epigenetically regulating HOXB7
expression. Cell Death Dis. 5:e12432014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang M, Lu W, Huang Y, Shi J, Wu X, Zhang
X, Jiang R, Cai Z and Wu S: Downregulation of the long noncoding
RNA TUG1 inhibits the proliferation, migration, invasion and
promotes apoptosis of renal cell carcinoma. J Mol Histol.
47:421–428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pan J, Li X, Wu W, Xue M, Hou H, Zhai W
and Chen W: Long non-coding RNA UCA1 promotes cisplatin/gemcitabine
resistance through CREB modulating miR-196a-5p in bladder cancer
cells. Cancer Lett. 382:64–76. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsai MM, Wang CS, Tsai CY, Chen CY, Chi
HC, Tseng YH, Chung PJ, Lin YH, Chung IH, Chen CY and Lin KH:
MicroRNA-196a/−196b promote cell metastasis via negative regulation
of radixin in human gastric cancer. Cancer Lett. 351:222–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
White NM, Khella HW, Grigull J, Adzovic S,
Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA,
et al: miRNA profiling in metastatic renal cell carcinoma reveals a
tumour-suppressor effect for miR-215. Br J Cancer. 105:1741–1749.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Jin L, Chen D, Liu J, Su Z, Yang S,
Gui Y, Mao X, Nie G and Lai Y: Tumor suppressive miR-196a is
associated with cellular migration, proliferation and apoptosis in
renal cell carcinoma. Mol Med Rep. 14:560–566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kurozumi A, Goto Y, Okato A, Ichikawa T
and Seki N: Aberrantly expressed microRNAs in bladder cancer and
renal cell carcinoma. J Hum Genet. 62:49–56. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zamore PD and Haley B: Ribo-gnome: The big
world of small RNAs. Science. 309:1519–1524. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qiu MT, Hu JW, Yin R and Xu L: Long
noncoding RNA: An emerging paradigm of cancer research. Tumour
Biol. 34:613–620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eades G, Zhang YS, Li QL, Xia JX, Yao Y
and Zhou Q: Long non-coding RNAs in stem cells and cancer. World J
Clin Oncol. 5:134–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liz J and Esteller M: LncRNAs and
microRNAs with a role in cancer development. Biochim Biophys Acta.
1859:169–176. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Han Y, Liu Y, Gui Y and Cai Z: Long
intergenic non-coding RNA TUG1 is overexpressed in urothelial
carcinoma of the bladder. J Surg Oncol. 107:555–559. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vacotto M, Coso O and de Plazas Fiszer S:
Programmed cell death and differential JNK, p38 and ERK response in
a prenatal acute hypoxic hypoxia model. Neurochem Int. 52:857–863.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen CY, Weng YH, Chien KY, Lin KJ, Yeh
TH, Cheng YP, Lu CS and Wang HL: (G2019S) LRRK2 activates MKK4-JNK
pathway and causes degeneration of SN dopaminergic neurons in a
transgenic mouse model of PD. Cell Death Differ. 19:1623–1633.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wong CH, Iskandar KB, Yadav SK, Hirpara
JL, Loh T and Pervaiz S: Correction: Simultaneous induction of
non-canonical autophagy and apoptosis in cancer cells by
ROS-dependent ERK and JNK activation. PLoS One. 11:e01593522016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Osaki M, Oshimura M and Ito H: PI3K-Akt
pathway: Its functions and alterations in human cancer. Apoptosis.
9:667–676. 2004. View Article : Google Scholar : PubMed/NCBI
|
